Belvedere Trading LLC Cassava Sciences Inc Put Options Transaction History

Belvedere Trading LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 09, 2024	BUY	$18.44 - $26.41 $477,596 - $684,019	25,900 Added 996.15%	28,500 $578,000
Q4 2023 Feb 13, 2024	SELL	$12.64 - $30.11 $58,144 - $138,506	-4,600 Reduced 63.89%	2,600 $58,000
Q3 2023 Oct 27, 2023	SELL	$16.64 - $25.32 $171,392 - $260,796	-10,300 Reduced 58.86%	7,200 $119,000
Q2 2023 Aug 08, 2023	BUY	$21.59 - $27.88 $62,611 - $80,852	2,900 Added 19.86%	17,500 $429,000
Q1 2023 May 15, 2023	SELL	$23.46 - $36.44 $968,898 - $1.5 Million	-41,300 Reduced 73.88%	14,600 $352,000

Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $1.28 Million - $2.03 Million	45,900 Added 459.0%	55,900 $1.65 Million
Q3 2022 Oct 26, 2022	BUY	$16.33 - $51.06 $163,299 - $510,600	10,000 New	10,000 $343,000

172

11.3M

1.61M

1.43M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $432M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.